Torrent Pharma Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Torrent Pharma Quarterly Results    (TORR)

Here are the latest quarterly results of Torrent Pharma. For more details, see the Torrent Pharma financial fact sheet and Torrent Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Torrent Pharma Quarterly Results

No. of Mths
Qtr. Ending
3
Mar-18
*
3
Jun-18
*
3
Sep-18
*
3
Dec-18
*
3
Mar-19
*
3
Jun-19
*
3
Sep-19
*
3
Dec-19
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m17,22018,72018,94020,51018,56020,22020,05019,660 
Other income Rs m42027010030170200340530 
Turnover Rs m17,64018,99019,04020,54018,73020,42020,39020,190 
Expenses Rs m13,58013,95014,21014,90013,83014,81014,64014,260 
Gross profit Rs m3,6404,7704,7305,6101,1605,4105,4105,400 
Depreciation Rs m1,5101,5001,5201,5601,6001,6001,6301,630 
Interest Rs m1,2101,2201,2601,3301,2301,2201,1601,110 
Profit before tax Rs m1,3402,3202,0502,750-1,5002,7902,9603,190 
Tax Rs m-94069026029020630520680 
Profit after tax Rs m2,2801,6301,7902,460-1,5202,1602,4402,510 
Gross profit margin %21.125.525.027.46.326.827.027.5 
Effective tax rate %-70.129.712.710.5-1.322.617.621.3 
Net profit margin %13.28.79.512.0-8.210.712.212.8 
Diluted EPS Rs 13.5 9.6 10.6 14.5 -9.0 12.8 14.4 14.8  
Diluted EPS (TTM) Rs 40.1 38.6 37.1 48.2 25.8 28.9 32.7 33.0  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: Torrent Pharma 3QFY20 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   PIRAMAL ENTERPRISES  NOVARTIS  FULFORD INDIA  STRIDES PHARMA SCIENCE  NATCO PHARMA  

Compare TORRENT PHARMA With:   PIRAMAL ENTERPRISES  NOVARTIS  FULFORD INDIA  STRIDES PHARMA SCIENCE  NATCO PHARMA  

Compare TORRENT PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Crashes 807 Points on Coronavirus Fears; Metal and Automobile Stocks Fall(Closing)

Indian share markets fell sharply today, tracking a global selloff as coronavirus cases spiked outside China.

Views on news

TORRENT PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 2.0% (Quarterly Result Update)

Jan 28, 2020 | Updated on Jan 28, 2020

For the quarter ended December 2019, TORRENT PHARMA has posted a net profit of Rs 3 bn (up 2.0% YoY). Sales on the other hand came in at Rs 20 bn (down 4.1% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 36.3% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, TORRENT PHARMA has posted a net profit of Rs 2 bn (up 36.3% YoY). Sales on the other hand came in at Rs 20 bn (up 5.9% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

More Views on News

Most Popular

The Next Few Days Are Crucial for Smallcap Investors - And 3 Must-Buy Stocks (Profit Hunter)

Feb 19, 2020

While I have been writing about the rebound in smallcaps for quite some time now... I have shied from the question - When exactly is the smallcap rebound happening. Well, the answer is now.

This Smallcap Stock Could be the Next Titan (Up 1,400% in 10 Years) (Profit Hunter)

Feb 11, 2020

A blueprint to latch on to the next 'Crorepati' stock - and an event I hope you won't miss on any account.

Here's Why I Recommended 15 Stocks in One Day Flat Views On News (Views On News)

Feb 14, 2020

This proven strategy can give big returns in quick time.

The Top 8 Trading Mistakes You Should Avoid (Fast Profits Daily)

Feb 18, 2020

Avoid these mistakes and your trading will turn much more profitable.

These Rebirth of India Stocks Are Raring to Compete with Tesla (The 5 Minute Wrapup)

Feb 17, 2020

There are Indian stocks which can soar like Tesla in the long-run.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

TORRENT PHARMA SHARE PRICE


Feb 24, 2020 (Close)

TRACK TORRENT PHARMA

  • Track your investment in TORRENT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TORRENT PHARMA

TORRENT PHARMA 5-YR ANALYSIS

COMPARE TORRENT PHARMA WITH

MARKET STATS